These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12475788)

  • 1. Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K(+) currents in beta-cells: a possible glucose-dependent insulinotropic mechanism.
    MacDonald PE; Salapatek AM; Wheeler MB
    Diabetes; 2002 Dec; 51 Suppl 3():S443-7. PubMed ID: 12475788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
    MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
    J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
    Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
    Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
    Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
    Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
    Holz GG
    Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-1 in rat pancreatic beta-cells.
    Suga S; Kanno T; Ogawa Y; Takeo T; Kamimura N; Wakui M
    Pflugers Arch; 2000 Aug; 440(4):566-72. PubMed ID: 10958340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
    Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
    J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for glucagon-like peptide-1 receptor signaling to activate ATP-sensitive potassium channels in pancreatic beta cells.
    Kwon HJ; Park HS; Park SH; Park JH; Shin SK; Song SE; Hwang M; Cho HC; Song DK
    Biochem Biophys Res Commun; 2016 Jan; 469(2):216-21. PubMed ID: 26655814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons.
    Gaisano GG; Park SJ; Daly DM; Beyak MJ
    Neurogastroenterol Motil; 2010 Apr; 22(4):470-9, e111. PubMed ID: 20003076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.
    Gromada J; Bokvist K; Ding WG; Holst JJ; Nielsen JH; Rorsman P
    Diabetes; 1998 Jan; 47(1):57-65. PubMed ID: 9421375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis.
    Kim SJ; Choi WS; Han JS; Warnock G; Fedida D; McIntosh CH
    J Biol Chem; 2005 Aug; 280(31):28692-700. PubMed ID: 15955806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
    Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
    Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
    Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
    Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells.
    Moens K; Berger V; Ahn JM; Van Schravendijk C; Hruby VJ; Pipeleers D; Schuit F
    Diabetes; 2002 Mar; 51(3):669-75. PubMed ID: 11872665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.